CDKN2B and idiopathic pulmonary fibrosis: CDKN2B is an inhibitor of cyclin-dependent kinases 4 and 6 and is a key regulator of cell cycle arrest [30]; thus, increased methylation followed by decreased CDKN2B expression might be expected to contribute to the reported increase in proliferation observed in IPF fibroblasts [5], [6].